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The region of the rubella virus nonstructural open reading frame that contains the papain-like cysteine
protease domain and its cleavage site was expressed with a Sindbis virus vector. Cys-1151 has previously been
shown to be required for the activity of the protease (L. D. Marr, C.-Y. Wang, and T. K. Frey, Virology
198:586–592, 1994). Here we show that His-1272 is also necessary for protease activity, consistent with the
active site of the enzyme being composed of a catalytic dyad consisting of Cys-1151 and His-1272. By means of
radiochemical amino acid sequencing, the site in the polyprotein cleaved by the nonstructural protease was
found to follow Gly-1300 in the sequence Gly-1299–Gly-1300–Gly-1301. Mutagenesis studies demonstrated that
change of Gly-1300 to alanine or valine abrogated cleavage. In contrast, Gly-1299 and Gly-1301 could be
changed to alanine with retention of cleavage, but a change to valine abrogated cleavage. Coexpression of a
construct that contains a cleavage site mutation (to serve as a protease) together with a construct that contains
a protease mutation (to serve as a substrate) failed to reveal trans cleavage. Coexpression of wild-type
constructs with protease-mutant constructs also failed to reveal trans cleavage, even after extended in vitro
incubation following lysis. These results indicate that the protease functions only in cis, at least under the
conditions tested.
Rubella virus (RUB), an enveloped, positive-strand RNA
virus, is the sole member of the Rubivirus genus of the family
Togaviridae (for a review, see reference 14). The 9,759-nucle-
otide genomic RNA contains two long open reading frames
(ORFs) organized in a manner similar to the genomes of the
members of the genus Alphavirus, the other genus in the To-
gaviridae (reviewed in reference 34). The 39-proximal ORF,
3189 nucleotides in length, encodes the three structural pro-
teins, consisting of a capsid protein (C) and two envelope
glycoproteins (E1 and E2). The 59-proximal ORF, 6615 nucle-
otides in length, encodes the viral nonstructural proteins (11).
Compared with alphaviruses, little is known about the trans-
lation and processing of the RUB nonstructural proteins.
Analysis of the deduced amino acid sequence of the nonstruc-
tural protein ORF (NSP-ORF) revealed the presence of two
amino acid motifs conserved among positive-polarity RNA
viruses, a GDD motif indicative of replicase activity and a
GK(S/T) motif indicative of helicase function. Another RUB
motif, of unknown function, X, is present in the genomes of
alphaviruses, hepatitis E virus, and coronaviruses but not other
RNA viruses. Interestingly, the order of the X motif and the
helicase motif in RUB is reversed compared with that in al-
phaviruses.
Computer-assisted sequence alignment revealed that a re-
gion of the RUB NSP-ORF between the X motif and the
helicase motif shared significant homology with several viral
and cellular papain-like cysteine proteases, including the nsP2
protease which resides within the alphavirus NSP-ORF (16).
The catalytic dyad residues of the RUB NS protease predicted
from the alignment were Cys-1151 and His-1272. Cleavage of
the polypeptide precursor translated from the RUB NSP-ORF
was first demonstrated by expression of the NSP-ORF in a
vaccinia virus transient-expression system (24). In that study,
three NSP-ORF-specific proteins, P200, P150, and P90 (mo-
lecular masses of 200, 150, and 90 kDa, respectively), were
identified. When one of the predicted catalytic amino acids,
Cys-1151, was changed to Gly, P150 and P90 disappeared,
demonstrating that a RUB NS protease is responsible for the
proteolytic processing of the precursor P200 to P150 and P90
and supporting the hypothesis that Cys-1151 is a component of
the catalytic site. Deletion mapping showed that both the pro-
tease domain and its cleavage site are located between amino
acids 1005 and 1507 of the NSP-ORF. Subsequently, region-
specific antisera produced by injection of rabbits with fusion
proteins expressed in Escherichia coli were used to confirm that
in RUB-infected cells only the cleavage of P200 to P150 and
P90 could be detected, and the order in the NSP-ORF was
found to be NH2-P150-P90-COOH (13). Thus, the RUB NSP-
ORF appears to be cleaved only once by the NS protease, in
contrast to alphaviruses, in which the nsP2 protease cleaves
three sites in the NSP-ORF precursor.
The goal of this study was to provide support for the hy-
pothesis that His-1272 is a component of the catalytic dyad of
the RUB NS protease and to determine the site of cleavage in
the NSP-ORF. For many positive-strand RNA viruses, such
analyses have been performed with products translated in cell-
free systems (8, 12, 32). However, we have been unable to
demonstrate proteolytic processing by the RUB NS protease
following translation of the NSP-ORF in standard reticulocyte
lysates (15). Therefore, for this work, part of RUB NSP-ORF
containing the putative protease domain and its cleavage site
was expressed in BHK cells by using a Sindbis virus vector (4).
Although Sindbis virus vectors have not been used extensively
in expression studies, proteins expressed by these vectors are
produced in abundance and are processed authentically (7,
27). An advantage of Sindbis virus vectors over the commonly
used vaccinia virus vectors is that insertion of the sequences to
be expressed is by in vitro ligation rather than by in vivo
recombination, simplifying the expression of site-specific mu-
tations made within the expressed sequences. The fragment of
the RUB NSP-ORF expressed by the Sindbis virus vector was* Corresponding author.
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found to self-cleave, allowing site-specific mutagenesis and se-
quence analysis to be performed.
MATERIALS AND METHODS
Plasmid construction. The dsSIN expression vector, Toto2JC1, and the shuttle
vector, pH2J1 (4), were provided by Charles Rice. Since the RUB genome
contains several XhoI sites, a unique MluI site was introduced in both plasmids
immediately downstream of the XhoI site normally used for linearization for
runoff transcription. Two fragments from the RUB genome, NSPro1 (nucleo-
tides 2515 to 4560) and NSPro2 (nucleotides 3053 to 4560), were amplified by
PCR from Robo12, a plasmid containing a cDNA copy of the RUB genome (35)
(shown schematically in Fig. 1A). For production of the NSPro1 fragment, the
upstream primer (primer 1) was CGCTCTAGATCATGATGGACCCACCGCC
CGGC and the downstream primer (primer 2) was CGCGGATCCTACTAGAC
CTGGCGGCCGTCCCA. For production of the NSPro2 fragment, the up-
stream primer (primer 3) was CGCTCTAGACCATGGGTGACCCGGGCC
GACCG and the downstream primer was primer 2. The primers contained
restriction sites for cloning, XbaI in primers 1 and 3 and BamHI in primer 2
(underlined in the primer sequences), as well as new start codons in the upstream
primers and new stop codons in the downstream primer (shown in boldface type
in the primer sequences) to allow translation of appropriate products from these
internal fragments. The NSPro1* and NSPro2* fragments were generated with
the same primer sets and with pTM3/nsRUB* as a template; pTM3/nsRUB* is
a plasmid that contains a copy of the RUB NSP-ORF in which Cys-1151 is
changed to Gly (24). The NSPro1, NSPro1*, NSPro2, and NSPro2* PCR prod-
ucts were digested with XbaI and BamHI and introduced into pH2J1 between the
XbaI and BamHI sites in the polylinker. Subsequently, the XbaI-MluI fragments
from the pH2J1-NsPro constructs were transferred to Toto2JC1 between the
XbaI and MluI sites. All PCRs were performed in a volume of 200 ml in the
FIG. 1. Regions of RUB NSP-ORF expressed by dsSIN recombinants and mutagenesis strategy. (A) In the diagram of the RUB genome, ORFs and nontranslated
regions are represented by open boxes and lines, respectively (NSP-ORF, nonstructural protein ORF; SP-ORF, structural protein ORF). Within the NSP-ORF, the
X, protease, helicase, and replicase domains are indicated as X, P, H, and R, respectively. The boundaries of the NSPro1 and NSPro2 fragments, which were generated
by PCR and introduced into the dsSIN vector, are shown. AA, amino acids. (B) Oligonucleotide-directed, site-specific mutagenesis was done by PCR by incorporating
the mutation into one member of the primer pair. The amplification product containing the mutation was introduced into pH2J1-NSPro2 at convenient restriction sites.
At the top is a map of the NSPro sequence showing the primer pairs used in each mutagenesis and restriction sites used to introduce mutations into pH2J1-NSPro2.
The arrows denote the orientation of each primer; the stars indicate the primer that contained the mutation. One mutation created a HindIII site which was used in
subsequent mutagenesis. At the bottom, the sequences of the primers are given; underlines denote restriction sites, and letters in boldface type denote the changed
nucleotides (nt).
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manufacturer’s (Amersham Life Science) buffer (50 mM Tris-HCl [pH 9.0], 1.5
mMMgCl2, 0.02 mM ammonium sulfate), containing 200 mM each deoxynucleo-
side triphosphate (dNTP), 1 mM each primer, 20 ml of dimethyl sulfoxide, 16 ml
of bovine serum albumin, 7 ml of 1% 2-mercaptoethanol, and 5 U of Hot tub
DNA polymerase (Amersham Life Science), for 30 cycles (948C for 1 min,
reduction to 558C over 2 min, increase to 728C over 2 min, 728C for 3 min)
followed by a 10-min extension at 728C in a Perkin-Elmer Cetus thermal cycler.
For recombinant plasmid constructions, standard recombinant DNA techniques
as described by Sambrook et al. (28) were used with minor modifications.
Site-directed mutagenesis of the RUB NSP sequence. Oligonucleotide-di-
rected site-specific mutagenesis was done by PCR by incorporating the mutation
into one of the pair of primers. The product amplified with these primers from
a Robo12 template was introduced into pH2J1-NSPro2 by using convenient
restriction sites followed by transfer into Toto2JC1. The PCR fragment was
sequenced after introduction into either pH2J1 or Toto2JC1 to confirm the
presence of the mutation introduced and to ensure that no other mutations were
introduced during PCR amplification. A diagram of the strategy and the se-
quences of the oligonucleotides used in mutagenesis are shown in Fig. 1B. No
suitable restriction site was present near the nucleotides encoding the cleavage
site, and for mutagenesis of the cleavage site a unique HindIII site (AAGCTT)
was created near the cleavage site by introducing two silent changes (CAGGCGT
to CAAGCTT).
Production of recombinant dsSIN viruses. BHK-21 cells were grown at 358C
under 5% CO2 in Dulbecco’s modified Eagle’s medium (Gibco/BRL) containing
10% fetal bovine serum and 50 mg of gentamicin per ml. To produce stocks of
recombinant viruses, 3 to 4 mg of each Toto2JC1 recombinant plasmid was
linearized withMluI and transcribed in vitro with SP6 polymerase in the presence
of cap analog (35). An aliquot of the transcription reaction mixture was used to
transfect 5 3 106 BHK cells by electroporation (23). The supernatant was
harvested at 24 h posttransfection. Titers of recombinant virus stocks ranged
from 5 3 108 to 1 3 109 PFU/ml. For dsSIN recombinants containing mu-
tagenized NSPro inserts, the presence of the mutation in the virus was confirmed
as follows. Recombinant virus stock (250 to 500 ml) was extracted with Tri-
Reagent LS (Molecular Research Center) as specified by the manufacturer, and
virion RNA was collected by isopropanol precipitation. The virion RNA was
used in a reverse transcription-PCR with a 100-ml volume of mixture containing
10 mM Tris-HCl (pH 8.3), 50 mM KCl, 5 mMMgCl2, 10 mM dithiothreitol, 1.25
mM each dNTP, 1 mM each primer (the upstream primer was primer 3; the
downstream primer was CTGATATTGTAAGGGCC [complementary to nucle-
otides 4064-4080 of the RUB genome]), 2 U of RNasin RNase inhibitor (Pro-
mega), 20 U of avian myeloblastosis virus reverse transcriptase (Molecular Ge-
netic Resources), and 2.5 U of Taq polymerase (Perkin Elmer-Cetus). The
reverse transcription-PCRmixture was incubated at 428C for 60 min and 958C for
3 min and then subjected to 35 cycles of 958C for 1 min, 558C for 2 min, and 728C
for 3 min, followed by an extension at 728C for 10 min. Alternatively, the reverse
transcription reaction was completed before addition of the Taq polymerase. The
PCR product, which encompasses nucleotides 3053 to 4080 of the RUB genome,
was gel purified before being sequenced.
Protein preparation and analysis. Confluent monolayers of BHK cells in
six-well culture plates (containing about 107 cells per well) were infected with
each recombinant dsSIN virus at a multiplicity of infection of 10 PFU per cell. At
16 h postinfection, the medium was removed and replaced with Dulbecco’s
modified Eagle’s medium lacking methionine and containing 2% dialyzed fetal
bovine serum. Thirty minutes later, 35S-Translabel (1,108 Ci/mmol; ICN) or
[35S]methionine (1,150 Ci/mmol; Amersham) was added to the medium at 50
mCi/ml. The cells were labeled continuously for 1 h or labeled for 30 min and
then chased with Dulbecco’s modified Eagle’s medium containing 10% fetal
bovine serum for 1, 2, or 3 h. Following the radiolabeling protocol, the medium
was removed and the cells were rinsed three times with phosphate-buffered
saline and solubilized in 0.5 ml of RIPA buffer (1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 150 mM NaCl, 3 mM EDTA,
10 mM Tris [pH 7.6]) containing 50 mg of antipain-dihydrochloride (Boehringer
Mannheim) per ml or TNE buffer (10 mM Tris-HCl [pH 7.6], 150 mM NaCl, 3
mM EDTA) containing 1% Nonidet P-40. Following removal of nuclei by cen-
trifugation, the supernatants were mixed 1:1 with 23 Laemmli sample buffer (50
mM Tris-HCl [pH 6.8], 3% SDS, 10% glycerol, 1% 2-mercaptoethanol, 0.025%
bromphenol blue), boiled for 3 min, and electrophoresed in SDS-12% polyacryl-
amide gels (22). Alternatively, lysates were subjected to immunoprecipitation
followed by SDS-polyacrylamide gel electrophoresis (PAGE) (13).
Amino acid sequencing. BHK cells (5 3 107) in 60-mm culture plates were
infected with dsSIN/NSPro2 or dsSIN/NSPro2:Y1315M (a recombinant in which
the tyrosine residue at 1315 was replaced with methionine) at a multiplicity of
infection of 10 PFU per cell. At 16 h postinfection, the cells were radiolabeled for
3 h in medium containing 100 mCi of [35S]methionine (1,150 Ci/mmol; Amer-
sham Corp.) per ml or 100 mCi of [35S]methionine per ml and 50 mCi of
[3H]leucine per ml (47 Ci/mmol; Amersham Corp.). Following immunoprecipi-
tation, the protein A-Sepharose-immune complex conjugates were dissociated in
1% SDS–5% 2-mercaptoethanol–62.5 mM Tris (pH 7.6) at 1008C for 3 min, and
the supernatant was concentrated by rotary evaporation and resolved by SDS-
PAGE in a 15% polyacrylamide gel. The contents of the gel were electroblotted
onto a polyvinylidene difluoride membrane (Applied Biosystems) with a Bio-Rad
apparatus at 60 V at room temperature for 1.5 h in buffer containing 25 mM Tris
base (pH 8.3), 192 mM glycine, and 10% (vol/vol) methanol. The 24-kDa C-
terminal cleavage product was localized by autoradiography and excised from the
polyvinylidene difluoride blot. Radioactive sequence analysis was carried out by
G. Hathaway with a model 477A protein sequencer (Perkin Elmer/Applied
Biosystems Division). Samples were sequenced directly from the polyvinylidene
difluoride membrane by a modification of the normal Edman cycle together with
the instrument’s microblot cartridge. The radioactive amino acids were assayed
as their anilinothiazolinone derivatives by redirecting the effluent from the re-
action cartridge to a fraction collector, and fractions corresponding to each cycle
were assayed for radioactivity in a liquid scintillation counter.
RESULTS
Construction of dsSIN viruses that express the RUB NS
protease domain. The RUB NS protease domain and its cleav-
age site have been shown by deletion mapping to be located
within the domain composed of amino acids 1005 to 1507 (24).
Two regions of the RUB NSP-ORF containing this region
(NSPro1 [amino acids 826 to 1507] and NSPro2 [amino acids
1005 to 1507]) were introduced into the SIN expression vector
Toto2JC1; in this double-subgenomic (ds) vector, the RUB
sequences are expressed from a distinct mRNA transcribed
from the second subgenomic promoter (reviewed in reference
4). In dsSIN/NSPro1- or dsSIN/NSPro2-infected cell lysates,
three new proteins (Fig. 2A) were observed in addition to
those in SIN-infected cell lysates, and these proteins were
immunoprecipitated by specific anti-RUB NSP-ORF serum
(Fig. 2B). The NSPro1 proteins had apparent molecular
masses of 76, 52, and 24 kDa, whereas the NSPro2 proteins has
apparent masses of 56, 32, and 24 kDa. Two mutant constructs,
dsSIN/NSPro1* and dsSIN/NSPro2*, in which the catalytic
Cys-1151 was changed to Gly, synthesized only the 76- and
56-kDa proteins, respectively. These species therefore are the
full-length translation products, and the smaller NSP-ORF-
specific proteins are cleavage products. Since the NSPro2 se-
quence was truncated at its N terminus by 179 amino acids in
relation to NSPro1, leading to the reduction in the size of the
precursor from 76 kDa in NSPro1 to 56 kDa in NSPro2, a
similar size reduction should occur in the N-terminal cleavage
product of NSPro2 in comparison with NSPro1 whereas the
sizes of the C-terminal cleavage product of both constructs
should be similar. Thus, the 24-kDa cleavage product must be
the C-terminal cleavage product whereas the 52-kDa product
from NSPro1 and the 32-kDa product from NSPro2 are the
N-terminal products. In addition, in both dsSIN/NSPro2- and
dsSIN/NSPro2*-infected cells, a protein of 52 to 53 kDa was
immunoprecipitated by NSP-ORF-specific antisera (Fig. 2B).
The identity of this protein is unknown; however, because it
was produced by dsSIN/NSPro2*, its presence was not due to
activity of the RUB NS protease.
In the experiment in Fig. 2, dsSIN/NSPro-infected cells were
labeled for 1 h. In pulse-chase experiments, maximal product/
precursor ratios were reached after a 1-h chase and maintained
during a 3-h chase but significant amounts of precursor re-
mained (data not shown). Thus, cleavage occurred only di-
rectly after translation and was not complete.
Mutagenic analysis of the RUB protease domain. In general,
papain-like proteases have a catalytic dyad consisting of one
cysteine and one histidine residue. On the basis of computer
alignment, Cys-1151 and His-1272 in the RUB NSP-ORF were
proposed to form the catalytic dyad (16). We previously tested
the importance of Cys-1151 (24). We have now tested the
importance of His-1272, as well as that of the two neighboring
His residues, His-1247 and His-1289, by changing each indi-
vidually to leucine. As shown in Fig. 3, mutation of His-1272
completely abolished proteolytic activity whereas mutation of
either His-1247 or His-1289 had no effect. These results sup-
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port the hypothesis that Cys-1151 and His-1272 form a catalytic
dyad in the protease.
Determination of the cleavage site. Radiochemical sequenc-
ing was used to identify the cleavage site in the RUB NS
polyprotein. From the electrophoretic mobilities of the dsSIN/
NSPro2 cleavage products, the cleavage site should be between
residues 1290 and 1310, just downstream of the catalytic His-
1272. The cleavage sites of most viral papain-like proteases
follow amino acids with small side chains, such as glycine and
alanine (12, 17), and this region contained several candidate
GG and AA dipeptides. In one experiment, cells infected with
a construct in which Tyr-1315 was changed to methionine
(dsSIN/NSPro2:Y1315M) (this substitution had no effect on
the activity of the protease) were labeled with [35S]methionine
and the 24-kDa cleavage product was isolated and sequenced.
Radiolabeled peaks were observed in cycles 15 and 28 (Fig.
4A), which could be aligned with methionines at residues 1315
and 1328, indicating that cleavage occurs after Gly-1300. To
confirm the cleavage site, dsSIN/NSPro2 recombinant virus-
infected cells were doubly labeled with [35S]methionine and
[3H]leucine. Edman degradation of the 24-kDa cleavage prod-
uct yielded tritium peaks in cycles 10, 18, and 23 and a 35S peak
in cycle 28 (Fig. 4B), which aligned with leucines at residues
1310, 1318, and 1323, as well as with methionine at residue
1328 (Fig. 4B). Note that the 35S peak in cycle 15 in Fig. 4A was
not present, since dsSIN/NSPro2 expresses the 24-kDa protein
with tyrosine at residue 1315 rather than methionine. These
results unambiguously identify Gly-1301 as the N terminus of
the 24-kDa product.
Characterization of the RUB NS protease cleavage site. The
amino acid sequence P2-P1-P19 surrounding the RUB cleav-
age site is Gly-1299–Gly-1300–Gly-1301. It is noteworthy that
the corresponding residues in alphaviruses are Gly-Gly/Ala/
Cys-X, where X can be any of several amino acids (34). To test
the requirements for the three glycine residues in RUB, they
were each changed individually to alanine or to valine. As
shown in Fig. 5, changing any of the three glycines to valine
resulted in the complete abolition of cleavage (lanes V2, V1,
and V19). In contrast, changing glycine to alanine at the P2 and
P19 positions impaired but did not eliminate cleavage (lanes
A2 and A19) whereas this substitution at the P1 position re-
sulted in only minimally detectable cleavage (lane A1). Thus,
the RUB cleavage site is most sensitive to the identity of the P1
residue, but the P2 and P19 residues also contribute signifi-
cantly to cleavage site recognition.
Assay for trans activity of the RUB NS protease. To examine
whether the RUB NS protease can act in trans, the dsSIN/
NSPro2* mutant (which expresses a nonfunctional protease)
and the dsSIN/NSPro2:G1300V mutant (which expresses a
noncleavable cleavage site) were used to coinfect BHK cells at
a multiplicity of infection of 20 PFU per cell for each recom-
binant. Indirect-immunofluorescence experiments demon-
strated that when cells were infected individually with each
recombinant virus at this multiplicity, almost 100% of cells
expressed the RUB protein products (data not shown). In
coinfected cells, the functional protease expressed by dsSIN/
NSPro2:G1300V should act on the unimpaired cleavage site of
the dsSIN/NSPro2* product if the protease can act in trans.
However, as shown in Fig. 6A, only the 56-kDa precursor
protein was observed in coinfected cells and no cleavage prod-
ucts were detectable (lane NSPro2*1G1300V), indicating that
under these conditions, the protease does not function in trans.
FIG. 2. Expression of NSPro sequences by dsSIN viruses. BHK cells infected with the dsSIN vector or dsSIN recombinants (multiplicity of infection, 10 PFU per
cell) were labeled for 1 h with [35S]methionine at 16 h postinfection, after which the cells were solubilized with 13 RIPA buffer. (A) Infected-cell lysates were resolved
by SDS-PAGE. The left-hand lane contains molecular weight (MW) standards (denoted in the left margin in thousands). The SIN structural proteins are denoted in
the right margin. The NSPro products are indicated by stars. (B) SDS-PAGE following immunoprecipitation of the infected cell lysates with GU-6, an antiserum against
a fusion protein containing the region of the NSP-ORF present in NSPro (13). The apparent molecular weights (in thousands) of the immunoprecipitated products
are indicated. Lanes: NSPro1 and NSPro2, lysates of cells infected with dsSIN/NSPro1 and dsSIN/NSPro2, respectively; NSPro1* and Pro2*, lysates of cells infected
with mutant constructs in which Cys-1151 was replaced with Gly. Autoradiographs of PAGE gels were scanned with an Agfa Arcus II flatbed scanner operating with
Fotolook V2.05 under Adobe Photoshop V2.5 software. Prints were made with a Tektronics Phaser 440 dye sublimation printer with a monochrome ribbon.
FIG. 3. Identification of the catalytic His residue in the RUB NS protease.
Single amino acid substitutions were introduced into NSPro2 at the positions
shown in the schematic diagram at the top of the figure, and dsSIN/NSPro2
recombinants containing the mutations were generated. BHK cells infected with
dsSIN/NSPro2 or NSPro2 mutants were radiolabeled, lysed, and immunopre-
cipitated with GU-6 prior to resolution by SDS-PAGE, as shown at the bottom
of the figure. In the line marked cleavage, 1 indicates that cleavage occurred
and 2 indicates that the cleavage was abolished.
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As an additional approach to detect trans cleavage, BHK
cells were coinfected with dsSIN/NSPro1 and dsSIN/NSPro2*
or with dsSIN/NSPro1* and dsSIN/NSPro2. Both of these
coinfections were with one wild-type construct and one pro-
tease mutant construct. Since the sizes of the N-terminal cleav-
age product of the NSPro1 and NSPro2 constructs differ (Fig.
2), trans cleavage of the protease mutant template by the wild-
type construct would be detectable. However, as shown in Fig.
6B (lanes Pro11Pro2* and Pro1*1Pro2), in both coinfections
only the N-terminal product from cis cleavage by the wild-type
construct was present. Lysates from coinfected cells (in either
RIPA buffer or TNE-1% Nonidet P-40) were incubated for up
to 24 h at both room temperature and 358C, with the result that
no change in the cleavage pattern could be observed. Thus, as
in the previous experiment, we were unable to detect trans
cleavage.
DISCUSSION
We have shown that Cys-1151 and His-1272 are required for
catalytic activity by the RUB NS protease, consistent with the
prediction of Gorbalenya et al. (16) that these residues form
the catalytic dyad of a papain-like protease. Additional evi-
dence that the RUB NS protease belongs to the papain family
is that it is inhibited by E-64d, a specific inhibitor of thiol
protease activity (6a, 18, 20, 25). Other viral proteases belong-
ing to the viral papain-like protease family are the alphavirus
nsP2 protease, the equine arteritis virus (EAV; family Arteri-
viridae) nsP1 protease, the murine hepatitis virus (MHV; fam-
ily Coronaviridae) PLP-1, the potyvirus HC-Pro, the p29 and
p48 proteases of hypovirulence-associated virus (HAV) of
chestnut blight fungus, and possibly the leader protease of
foot-and-mouth disease virus (FMDV; genus Aphthovirus,
family Picornaviridae) (1, 2, 8, 12, 26, 29, 31, 32).
We also found that the cleavage site of the RUB NS pro-
tease followed Gly-1300, 28 residues downstream from the
catalytic His residue. An alignment of cleavage sites recog-
nized by viral papain-like proteases is shown in Fig. 7. The
most uniform feature of these sites is the presence of an amino
acid with a short side chain in the P1 position. The P19 position
is also usually occupied by an amino acid with a short side
chain. In particular, Gly-Gly is present in the P1-P19 position
not only in the RUB site but also in the EAV nsp1, potyvirus
HC-Pro, and HAV p29 sites. The RUB and alphavirus NS
cleavage sites share a Gly in the P2 position, whereas the sites
of the other viral proteases have bulky hydrophobic amino
acids or arginine in the P2 position. Notably, the Gly in the P2
position is the only residue that is strictly conserved in all 10
alphaviruses whose genomes have been sequenced (34). As is
the case for Gly in the P2 position of the RUB site, substitution
of the P2 Gly by alanine in the alphavirus cleavage sites is
tolerated, although the cleavage efficiency is reduced, but sub-
stitution by other amino acids results in a site completely re-
fractory to cleavage. Studies of the cleavage sites of the poty-
virus HC-Pro, the HAV p29 and p48 proteases, and the MHV
PLP-1 have also shown that the P2 residue is important for
substrate recognition by these proteases (5, 6, 12, 17, 29).
Although the P2 and P1 residues are similar between RUB and
alphavirus sites, the nature of the residues at the P3 and P19
positions is different. An Ala is usually present at the alphavi-
rus P3, but Arg is present in the RUB site. Alphaviruses tol-
erate amino acids with bulky side chains in the P19 position (a
Tyr in naturally present in the nsP3/nsP4 cleavage site of all
alphaviruses, and Phe, Met, and Arg are also tolerated in this
position [9, 10, 30]), whereas the RUB site is quite sensitive to
any change in the glycine present at P19. Similar to the RUB
cleavage site, the cleavage sites for the EAV nsP1 and potyvi-
rus HC-Pro proteases cannot tolerate substitution of the P19
Gly with a bulky amino acid (6, 31).
We were not able to detect trans cleavage by the RUB NS
FIG. 4. Sequencing of the NSPro2 C-terminal cleavage product. The 24-kDa
cleavage product from dsSIN/NSPro2:Y1315M-infected cells labeled with
[35S]methionine (A) or dsSIN/NSPro2-infected cells doubly labeled with [35S]me-
thionine and [3H]leucine (B) was isolated and subjected to Edman degradation, and
the radioactivity released during each cycle was determined. The amino acid se-
quences of NSPro2:Y1315M (A) and NSPro2 (B) are shown at the top of the panels.
FIG. 5. Mutagenesis of amino acids around the cleavage site. dsSIN/NSPro2
recombinants in which Gly in the P2, P1, or P19 position of the cleavage site
(amino acids 1299, 1300, and 1301) was substituted individually with Ala (A2, A1,
or A19, depending on whether the substitution was made at the P2, P1 or P19
position) or Val (V2, V1, or V19) were constructed. BHK cells infected with
dsSIN/NSPro2 (NSPro2), dsSIN/NSPro2* (NSPro2*) or the cleavage site mu-
tants were radiolabeled, lysed, and immunoprecipitated with GU-6, prior to
resolution by SDS-PAGE. The 56-kDa precursor and the 32- and 24-kDa N- and
C-terminal cleavage products are indicated.
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protease. It remains to be ascertained if trans activity is also
lacking when the protease is produced in its natural context of
the P200 precursor or P150 product. If, as it appears, the RUB
NS protease lacks trans activity, however, then it differs from
the activity of the alphavirus nsP2 protease. Interestingly,
members of the viral papain-like protease family have been
differentiated into two classes on the basis of their ability to
function in cis or trans (16). Main or M-proteases exhibit trans
activity and cleave at several sites within the viral polyprotein
precursor, whereas leader or L-proteases cleave in cis at a
single site. Thus far, the alphavirus nsP2 protease is the only
defined M-protease within the papain-like protease family,
although a number of viral proteases which are not papain-like
proteases exhibit this general type of activity (e.g., the picor-
navirus 3Cpro cysteine protease, the flavivirus NS3 serine pro-
tease, and the arterivirus serine protease [33]). The FMDV
leader protease also appears to be an M-protease, since it
cleaves its single site within the viral polyprotein precursor in
trans and also cleaves sites within cellular proteins in trans (19,
26). L-proteases, which include the EAV nsP1, the potyvirus
HC-Pro, and the HAV p29 proteases, cleave in cis at a single
site, which in each case is a Gly-Gly dipeptide situated 31 to 42
amino acids from the catalytic His residue. In contrast, the
single site cleaved in cis by the MHV PLP-1 is upstream from
the protease domain, and thus this enzyme differs from the
other L-proteases (17). There is evidence that this protease
cleaves at a second site in the MHV ORF-1 precursor and thus
may be an M-protease (3).
By these criteria, the RUB NS protease appears to belong to
the L-protease category, although Gorbalenya et al. (16) pre-
dicted that it would be an M-protease. However, the activity of
the RUB NS protease differs from that of the other L-pro-
teases in three regards. First, the RUB NS protease domain is
in the center of a long ORF and mediates the cleavage of a
polyprotein precursor into two mature products. In contrast,
the other L-proteases are located at the N termini of the ORFs
in which they reside and function to cleave off relatively short
“leader proteins.” The ORFs encoding the EAV nsP1 pro-
tease, the potyvirus HC-Pro, and the MHV PLP-1 encode
other proteases, which mediate more extensive processing of
the translation product of the ORF. Second, while the other
L-proteases cleave cotranslationally, the RUB NS protease
cleavage occurs after translation of the NSP-ORF is complete
(13). Third, the cleavage activity of the other L-proteases oc-
curs efficiently in vitro in a standard rabbit reticulocyte trans-
lation reaction, whereas the in vitro activity of the RUB NS
protease is detectable only in the presence of a HeLa cell
extract (15).
FIG. 6. Assay for cleavage in trans. (A) BHK cells were infected with dsSIN/
NSPro2 (lane NSPro2) or coinfected with dsSIN/NSPro2* (mutated catalytic site)
and dsSIN/NSPro:G1300V(V1) (mutated cleavage site) (lane NSPro2*1G1300V).
(B) BHK cells were infected with dsSIN/NSPro2 (lane NSPro2), dsSIN/NSPro1
(lane NSPro1), or dsSIN NSPro1* (lane NSPro1*) or coinfected with dsSIN/
NSPro1 and dsSIN/NSPro2* (lane Pro11Pro2*) or with dsSIN/NSPro1* and
dsSIN/NSPro2 (lane Pro1*1Pro2). In both experiments, after radiolabeling had
been carried out for 1 h at 16 h postinfection, cell lysates were prepared,
immunoprecipitated with GU-6, and resolved by SDS-PAGE. In both panels, the
precursor and cleavage products are denoted.
FIG. 7. Comparison of the amino acid sequence around cleavage sites of viral papain-like proteases. The P4 to P49 residues of the cleavage sites of the recognized
papain-like proteases of positive-strand RNA viruses are shown. Sequences are from MHV PLP-1 (12, 17), EAV nsP1 (31), HAV p28 and p48 (8, 29), and FMDV
(strain A12; L-VP4 cleavage is within the viral polyprotein precursor; the eIF site is in the cellular translation factor eIF-4g) (19, 26). The potyvirus HC-Pro cleavage
site is a consensus of sequences from around 20 potyviruses (4, 4a), and the alphavirus nsP2 cleavage sites are the consensus from 10 alphavirus sequences (34). In the
consensus sequences, underlined amino acids are invariant and X denotes no conservation at that position.
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Although RUB and the alphaviruses have a similar genomic
expression strategy and are classified in the same family, the
order of conserved motifs is different within the NSP-ORFs
(11), and phylogenetic analyses show that the helicase and
replicase domains of RUB and the alphaviruses are more
closely related to those of other viruses than to each other (21,
36). The results of this study suggest that the NS proteases of
these viruses differ in functional activity (which would explain
the difference in NSP processing exhibited by these viruses). It
is possible that these differences result from a different origin
of the RUB and alphavirus NS regions. It would be of interest
to determine if the RUB NS protease was more similar to viral
L-proteases, whose activities are similar to the RUB NS pro-
tease, or to the alphavirus NS protease. Unfortunately, the
viral papain-like proteases are too widely divergent to permit a
phylogenetic analysis of their linear sequences to answer this
question (16). Interestingly, however, in the alignment of viral
and cellular members of the papain-like protease family, the
only statistically significant relationship involving a viral pro-
tease was found to be between the RUB NS protease and
several cellular proteases, possibly indicating that the RUB NS
protease was only recently captured from cellular sources dur-
ing virus evolution. However, from the same alignment, a re-
semblance was proposed between the alphavirus nsP2 protease
and the potyvirus HC-Pro, a relationship which totally confuses
origin-function similarities among these proteases. Resolution
of the evolutionary relationship among the viral papain-like
proteases will probably require definition of their three-dimen-
sional structure.
Whatever the evolutionary origin of the RUB and alphavirus
NS proteases, the apparent difference in their function has
profound implications for the replication of the respective vi-
ruses. The processing of the alphavirus NSPs involves a sophis-
ticated cascade mediated by the NS protease which regulates
the course of virus RNA synthesis. In contrast, the apparent
single cis cleavage mediated by the RUB NS protease would
not allow this virus to evolve such an elaborate regulatory
process.
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